Skip to content

Canagliflozin Impurity 14

Canagliflozin Impurity 14

Product Description
CAT No.
ALN-C010038
CAS No.
NA
Mol. F.
C32H33FO9S
Mol. Wt.
612.7
Stock
Please Inquire
Chemical Name : (2R,3R,4R,5S,6S)-2-(Acetoxymethyl)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-2-methylphenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate
Smiles : CC1=C(CC2=CC=C(C3=CC=C(F)C=C3)S2)C=CC=C1[C@H]4[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O4
Inchi : InChI=1S/C39H44F2N8O5/c1-4-37(27(2)54-28(3)50)49-38(51)48(26-44-49)33-8-6-31(7-9-33)45-15-17-46(18-16-45)32-10-12-34(13-11-32)52-21-29-20-39(53-22-29,23-47-25-42-24-43-47)35-14-5-30(40)19-36(35)41/h5-14,19,24-27,29,37H,4,15-18,20-23H2,1-3H3/t27-,29+,37-,39-/m0/s1

Development and validation of HPLC method for determination of trace level potential genotoxic hydroperoxide impurity in canagliflozin

By Gosar, Amit; Shaikh, Tabrez; Botkondle, Suresh; Mahadik, Neelam; Tole, RahulnFrom International Journal of Pharma Research and Health Sciences (2019), 7(5), 3068-3071

Bioanalytical method development and validation of canagliflozin in human plasma by liquid chromatography-tandem mass spectrometry

By Deepan, T.; Rao, M. V. Basaveswara; Dhanaraju, M. D. – From Asian Journal of Pharmaceutical and Clinical Research (2019), 12(8), 46-51

Request For Quotation